Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
15/04/2021
0:00
15:06
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
D'autres épisodes de "JAMA Oncology Author Interviews"
Ne ratez aucun épisode de “JAMA Oncology Author Interviews” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.